Equipment and utensils are not cleaned at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality, or purity of the drug product.
Inspection Record
Guangxi Yulin Pharmaceutical Group Co. Ltd. — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
There is no written testing program designed to assess the stability characteristics of drug products.
Laboratory controls do not include the establishment ofscientifically sound and appropriate specifications, standards, and test procedures designed to assure that components and drug products conform to appropriate standards of identity, strength, quality and purity.
Written production and process control procedures are not followed in the execution of production and process control functions and documented at the time of performance.
Testing and release ofdrug product for distribution do not include appropriate laboratory determination of satisfactory conformance to the identity and strength of each active ingredient prior to release.
Strict control is not exercised over labeling issued for use in drug product labeling operations.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Glenmark Pharmaceuticals Inc USA2022-05-19 · US FDASimilar to finding 4 Written production and process control procedures are not followed in the execution ofproduction and process control functions and documented at the time of…
- Tripak Pharmaceuticals Pty Ltd.2025-07-25 · US FDASimilar to finding 2 There is no written testing program designed to assess the stability characteristics of drug products.
- Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.2025-03-07 · US FDASimilar to finding 1 Equipment and utensils are not cleaned at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of…
- Central Admixture Pharmacy Services Inc2023-08-25 · US FDASimilar to finding 4 Written production and process control procedures are not followed in the execution ofproduction and process control functions and documented at the time…
- Hybrid Pharma LLC2026-08-27 · US FDASimilar to finding 3 Laboratory controls, do not include the establishment of scientifically sound and appropriate specifications, standards, sampling plans and test procedures…
A record as of the US FDA document published on 2026-11-13. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.